Skip to main content
Clinical Trials/NCT05740046
NCT05740046CompletedNot Applicable

Influence of Motor Intervention With the Intorus Tool on the Psychomotor Development of Children With Down Syndrome

University of Extremadura2 sites in 1 country30 target enrollmentStarted: February 1, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
30
Locations
2
Primary Endpoint
Change in Berg Equilibrium Scale

Study Overview

Brief Summary

The goal of this clinical trial is to test in people with down syndrome how does the INTORUS tool influence their psychomotor development. The main question it aims to answer is:

  • Does the INTORUS tool improve psychomotor development in people with Down Syndrome? The intervention program will be carried out during the Functional Habilitation sessions and will be carried out by the center's professionals. These sessions must be carried out in a quiet environment, without distractions so that the user can concentrate on carrying out the activities. It is important that the user attends the sessions in comfortable, sleeveless clothing, to allow the tool to slide smoothly through their upper limbs.

Each session will consist of several exercises with their corresponding rest breaks described in the Intervention Protocol. Each session attendance will be recorded following an attendance record model created for the occasion.

Participants will be divided into two groups randomly. The control group will receive an intervention treatment at the psychomotor level in the traditional way, following the protocols established in the center, and the intervention group will receive an intervention treatment at the psychomotor level with the INTORUS device.

Randomization will be carried out using the Oxford Minimization and Randomization software.

Detailed Description

POPULATION The population of interest are users of the Functional Habilitation Service of the Centers of the Down Syndrome Association of Cáceres and Plasencia

INCLUSION CRITERIA

  • Users with Down Syndrome
  • Ages between 4 and 18 years.
  • Informed consent signed by parents/guardians.

EXCLUSION CRITERIA

  • Users without Down Syndrome.
  • Under 4 years and over 18 years.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
4 Years to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Users with Down Syndrome
  • Ages between 4 and 18 years.
  • Informed consent signed by parents/guardians.

Exclusion Criteria

  • Users without Down Syndrome.
  • Under 4 years and over 18 years

Outcomes

Primary Outcomes

Change in Berg Equilibrium Scale

Time Frame: Before starting the interventions, at 3 months and at 6 months at the end of the study.

Scale for measuring balance in people over 15 years of age. The Berg Balance Scale (BBS) is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function and takes approximately 20 minutes to complete. It does not include the assessment of gait.

Change in Pediatric Balanced Scale

Time Frame: Before starting the interventions, at 3 months and at 6 months at the end of the study.

The Pediatric Balance Scale is a modified version of the Berg Balance Scale that is used to assess functional balance skills in school-aged children. The scale consists of 14 items that are scored from 0 points (lowest function) to 4 points (highest function) with a maximum score of 56 points

Secondary Outcomes

  • Change in Harris test(Before starting the interventions, at 3 months and at 6 months at the end of the study.)

Investigators

Sponsor
University of Extremadura
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Blanca González Sanchez

DOCTOR

University of Extremadura

Study Sites (2)

Loading locations...

Similar Trials